Company Overview of Cellegy Australia Pty. Ltd.
Cellegy Australia Pty., Ltd. provides a therapeutic treatment for anal fissures. Its Rectogesic ointment contains glyceryl trinitrate in a base of liquid paraffin, soft yellow paraffin, lanolin, and ethanol. This product is used for the treatment and relief of symptoms of anal fissure. The company was formerly known as Quay Pharmaceuticals Pty., Ltd. As a result of Quay Pharmaceuticals acquisition by Cellegy Pharmaceuticals, Inc. in June 2000, its name was changed to Cellegy Australia Pty., Ltd. The company is based in Edgecliff, Australia. As of April 11, 2006, Cellegy Australia Pty., Ltd. is a subsidiary of Epsilon Pharmaceuticals.
203-233 New South Head Road
Level 5, Edgecliff Centre
Edgecliff, NSW 2027
Key Executives for Cellegy Australia Pty. Ltd.
Cellegy Australia Pty. Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|4G Vaccines Pty Ltd.||Asia|
|Advent Pharmaceuticals Pty Ltd.||Asia|
|AFT Pharmaceuticals Pty Ltd||Asia|
|Anagen Pty Limited||Asia|
|Ascend Biopharmaceuticals Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cellegy Australia Pty. Ltd., please visit www.rectogesic.com/index2.htm. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.